Innospec (IOSP) Q3 2026 earnings summary

Executive summary

• Q3 sales rose 7% YoY to $473.6M; operating income was $41.7M versus $5.9M, including special items in both periods.

• Adjusted EBITDA increased to $51.4M from $44.2M; GAAP and adjusted diluted EPS were both $1.29, versus $0.52 and $1.12, respectively, a year earlier.

• Performance Chemicals and Oilfield Services led operating income growth, while Fuel Specialties sustained strong results.

• Cash and cash equivalents were $251.9M with no debt at September 30.

Financial highlights

• Q3 gross profit increased 11% YoY to $129.1M; aggregate gross margin rose 0.9 percentage points to 27.3%.

• Adjusted EPS was $1.29 versus $1.12, up 15%; adjusted EBITDA was $51.4M versus $44.2M, up 16%.

• Q3 operating cash flow was $17.4M versus $39.1M, with capital expenditures of $15.6M.

• Nine-month sales rose 7% to $1,418.2M; operating cash flow fell to $42.2M from $77.9M, primarily reflecting higher working-capital increases.

Outlook and guidance

• Performance Chemicals Q4 results are expected to be similar to Q3; North Carolina upgrades are expected to support growth and margin improvement in 2027.

• Fuel Specialties expects continued strong performance and seasonal demand, with Q4 gross margin near its current level.

• Oilfield Services expects sequential improvement in Q4 and further sequential growth through 2027, subject to market developments.

• Free cash flow is expected at $40M-$50M in Q4 and $55M-$60M in 2027, assuming a stable backdrop and raw materials.

• 2026 capital expenditures are expected to be ~$60M, similar to 2025.